Skip to main content

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 177 Accesses

Abstract

Gliomas are the most common primary brain tumors,comprising 40-60% of all primary brain tumors.The most frequent types are glioblastoma multiforme, astrocytoma, and oligodendroglioma. Radiation therapy is one of the most important treatment modalities for gliomas, mainly because these tumors are usually localized. The patient¡¯s head can be immobilized, allowing for good targeting of the tumor. As a result of technological advances, the range of treatment options using radiation therapy has increased. Photon, electron, neutron and proton radiation beams are all in clinical use. The accuracy of the treatment delivery has also improved, with the development of three-dimensional techniques and image fusion. Our understanding of both the radio sensitivity of gliomas, and the tolerance of normal brain tissue is better, allowing the design of novel fractionation schemes. Radiation is being combined with both local and systemic chemotherapy, offering

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  • Barth RF, Soloway AH, Brugger RM (1996) Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest 14(6):534–550

    Article  PubMed  CAS  Google Scholar 

  • Barth RF, Soloway AH, Goodman JH, Gahbauer RA, Gupta N, Blue TE, Yang W, Tjarks W (1999) Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44(3):433–450; discussion 433–450

    Google Scholar 

  • Bleehen NM, Wiltshire CR, et al. (1981) A randomized study of misonidazole and radiotherapy for Grade 3 and 4 cerebral astrocytoma. Br J Cancer 43: 436–442

    Article  PubMed  CAS  Google Scholar 

  • Boiardi A, Silvani A, Pozzi A, Farinotti M, Fariselli L, Broggi G, Salmaggi A (1997) Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy. J Neurooncol 34(2):179–185

    Article  PubMed  CAS  Google Scholar 

  • Bouchard J (1966) Radiation therapy of intracranial tumors long term results. Acta Radiol Ther Phys Biol. 5:11–16

    Article  PubMed  CAS  Google Scholar 

  • Brady LW, Markoe AM, Woo DV, Rackover MA, Koprowski H, Steplewski Z, Peyster RG (1990) Iodine125 labeled antiepidermal growth factor receptor-425 in the treatment of malignant astrocytomas. A pilot study. J Neurosurg Sci.34(3–4):3–4

    PubMed  CAS  Google Scholar 

  • Brandes AA, Fiorentino MV (1996) The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest:14 (6):551–559

    Article  PubMed  CAS  Google Scholar 

  • Burger, PC (1987): The anatomy of Astrocytomas (editorial).Mayo Clin Proc 62:527–529

    Article  PubMed  CAS  Google Scholar 

  • Burger PC, Mahaley MS Jr, Dudka L, Vogel FS (1979) The morphologic effects of radiation administered therapeutically for intracranial gliomas. Cancer 44: 1256–1272

    Article  PubMed  CAS  Google Scholar 

  • Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T,Buckner J, Fulton D, Dropcho E, Stewart D, Schold C Jr, etal. (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12(10):2013–2021

    PubMed  CAS  Google Scholar 

  • Cardinale RM, Schmidt-Ullrich RK, Benedict SH, Zwicker RD, Han DC, Broaddus WC (1998) Accelerated radiotherapy regimen for malignant gliomas using stereotactic concomitant boosts for dose escalation. Radiat Oncol Investig 6(4):175–181

    Article  PubMed  CAS  Google Scholar 

  • Caveness WF (1977) Pathology of radiation damage to the normal brain of the monkey. Natl Cancer Inst Monogr 46:57–76

    PubMed  CAS  Google Scholar 

  • Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB (1999) Single dose versus fractionated stereotactic radiotherapy or recurrent high-grade gliomas. Int J Radiat ncol Biol Phys 45(5):1133–1141

    Article  CAS  Google Scholar 

  • Chong VFH, Rumpel H, Aw YS, Ho GL, Fan YF, Chua EJ (1999) emporal Lobe Necrosis Following Radiation Therapy for asopharyngeal Carcinoma: 1H MR Spectroscopic Findings.Int J Radiation Oncology Biol Phys 45(3): 699–705

    Article  CAS  Google Scholar 

  • Chung YG, Kim CY, Lee HK, Lee KC, Chu JW, Choi MS (1995) reliminary experiences with intraoperative radiation therapy (IORT) for the treatment of brain tumors. J Korean ed Sci 10(6):449–452

    Google Scholar 

  • Crosby TD, Melcher AA, Wetherall S, Brockway S, Burnet NG 1998) A comparison of two planning techniques for radiotherapy f high grade astrocytomas. Clin Oncol (RColl Radiol) 10(6):392–398

    Article  CAS  Google Scholar 

  • Edwards MS, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, Wilson CB, Hannigan J, Silver P (1989) Hyperfractionated radiation therapy for brainstem glioma: a phase I-II trial. J Neurosurg. 70(5):691–700

    Article  PubMed  CAS  Google Scholar 

  • EORTC Brain Tumour Group (1978): Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain gliomafinal evaluation. Eur. J. Cancer 14: 851–856

    Google Scholar 

  • Erlich, SS and Davis, RL (1978) Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42: 2854–2864

    Article  PubMed  CAS  Google Scholar 

  • Faillot T, Magdelenat H, Mady E, Stasiecki P, Fohanno D, Gropp P, Poisson M, Delattre JY (1996) A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas. Neurosurgery 39(3):478–483

    PubMed  CAS  Google Scholar 

  • Fine HA, Dear KBG, Loeffler, JS, Black, PM, Canellos, GP (1993) Meta-Analysis of Radiation Therapy With and Without Adjuvant Chemotherapy for Malignant Gliomas in Adults. Cancer 71: 2585–2597

    Article  PubMed  CAS  Google Scholar 

  • Fischman AJ, Thornton AF, Frosch MP, Swearinger B,Gonzalez RG, Alpert NM (1997) FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med. 38(7):1027–1029

    CAS  Google Scholar 

  • Fontanesi J, Clark WC, Weir A, Barry A, Kumar P, Miller A, Eddy T, Tai D, Kun LE (1993) Interstitial iodine 125 and concomitant cisplatin followed by hyperfractionated external beam irradiation for malignant supratentorial glioma. Preliminary experience at the University of Tennessee,Memphis. Am J Clin Oncol 16(5):412–417

    Article  PubMed  CAS  Google Scholar 

  • Fountzilas G, Karavelis A, Makrantonakis P, Selviaridis P, Tzitzikas J, Kalogera-Fountzila A, Hatzibaloglou A, Karkavelas G, Foroglou G, Tourkanotonis (1997) Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas: a feasibility study. Am J Clin Oncol 20(2): 138–142

    Article  PubMed  CAS  Google Scholar 

  • Fowler JF (1984) Non-standard fractionation in radiotherapy. Int J Radiat Oncol Biol Phys. 10(5):755–759

    Article  PubMed  CAS  Google Scholar 

  • Freeman JE, Johnston PGB, Voke JM (1973) Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J 4: 523–525

    Article  PubMed  CAS  Google Scholar 

  • Gaspar LE, Fisher BJ, et al. (1993) Malignant Glioma-Timing of Response to Radiation Therapy. Int J Radiat Oncol BiolPhys 25(5):877–879

    Article  CAS  Google Scholar 

  • Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma astrocytomas with PCV chemotherapy. J Neurosurg 76(5):741–745

    Google Scholar 

  • Groothuis DR, Vick NA (1980) Radionecrosis of the central nervous system: the perspective of the clinical neurologist and neuropathologist. In: Gilbert HA, Kagan AR (Eds), Radiation Damage to the Nervous Sustem. A Delayed Therapeutic Hazard, 93--106, Raven Press, New York

    Google Scholar 

  • Gupta N, Vij R, Haas-Kogan DA, Israel MA, Deen DF, Morgan WF (1996) Cytogenetic damage and the radiation-induced G1-phase checkpoint. Radiat Res 145(3):289–298

    Article  PubMed  CAS  Google Scholar 

  • Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P, et al. (1991) External irradiation followed by an interstitial high activity iodine-125 implant ¡°boost¡± in the initial treatment of malignant gliomas: NCOG study 6G-82–2. Int J Radiat Oncol Biol Phys 21(3):82–2

    Article  PubMed  CAS  Google Scholar 

  • Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M, Clark HB (1995) Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13(7):1642–1648

    PubMed  CAS  Google Scholar 

  • Hatanaka, H, Nakagawa, Y (1994) Clinical Results of LongSurviving Brain Tumor Patients Who Underwent Boron Neutron Capture Therapy. Int J Radiat Oncolo Biol Phys 28(5): 1061–1066

    Article  CAS  Google Scholar 

  • Hawthorne MF, Wiersema RJ, Takasugi M (1972) Preparation of tumor-specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets. J Med Chem 15(5):449–452

    Google Scholar 

  • Hazle JD, Jackson EF, Schomer DF, Leeds NE (1997) 1234 AJNR Am J Neuroradiol 18(9):1753–1761

    Google Scholar 

  • Hellman R, Neuberg DS, Wagner H, Grunnet M, Robins HI, Karp D, Flynn P, Adams G (1998) A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas an Eastern Cooperative Oncology Group Study (E2392). J Neurooncol 37(1):55–62

    Article  PubMed  CAS  Google Scholar 

  • Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH (1995) Selective tumor kill of cerebral glioma by photodynamictherapy using a boronated porphyrin photosensitizer.Proc Natl Acad Sci USA 92(26):12126–12130

    Article  PubMed  CAS  Google Scholar 

  • Hopkins K, Chandler C, Bullimore J, Sandeman D, Coakham H, Kemshead JT (1995) A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates. Radiother Oncol 34(2):121–131

    Article  PubMed  CAS  Google Scholar 

  • Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A, Aleksandrovic J (1999) Combined treatment modality for anaplastic oligodendroglioma: aphase II study. J Neurooncol 43(2):179–185

    Article  PubMed  CAS  Google Scholar 

  • Kelland LR, Edwards SM, Steel GG (1988) Induction and rejoining of DNA double-strand breaks in human cervix carcinoma cell lines of differing radiosensitivity. Radiat Res 116(3):526–538

    Article  PubMed  CAS  Google Scholar 

  • Kelly PJ, Duport CD, Scheithauer BW, Kall BA and Kespert DB (1987) Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62;450–459

    Article  PubMed  CAS  Google Scholar 

  • Kim L, Hochberg FH, Thornton AF, Harsh GR 4th, Patel H, Finkelstein D, Louis DN (1996) Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 85(4):602–607

    Article  PubMed  CAS  Google Scholar 

  • Kiu MC, Chang CN, Cheng WC, Lin TK, Wong CW, Tang SG, Leung WM, Chen LH, Ho YS, Ng KT, et al. (1995) Combination chemotherapy with Carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas. J Neurooncol 25(3):215–220

    Article  PubMed  CAS  Google Scholar 

  • Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495–497

    Article  PubMed  CAS  Google Scholar 

  • Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41(4):776–783

    Article  PubMed  CAS  Google Scholar 

  • Kyritsis AP, Yung WK, Jaeckle KA, Bruner J, Gleason MJ, Ictech SE, Flowers A, Levin VA (1996) Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. Neurosurgery 39(5):921–926

    PubMed  CAS  Google Scholar 

  • Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein M (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41(5):1005–1011

    Article  PubMed  CAS  Google Scholar 

  • Laramore GE, Spence AM (1996) Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note. Int J Radiat Oncol Biol Phys 36(1):241–246

    Article  PubMed  CAS  Google Scholar 

  • Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, Radany EH, Lichter AS, Sandler HM (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43(1):79–88

    Article  PubMed  CAS  Google Scholar 

  • Levin VA, Prados MD, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB (1995) Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine,lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 32:75–83

    Article  PubMed  CAS  Google Scholar 

  • Libermann T, Nusbaum H, Razon N, Kris R, Lux I, Soreq H, Whittle M, Waterfield M, Ullrich A, Schlessinger J (1985) Amplification and overexpression of the EGF recceptor gene in primary human glioblastomas. J Cell Sci Suppl 3:161–172

    PubMed  CAS  Google Scholar 

  • Liu L, Barth RF, Adams DM, Soloway AH, Reisfeld RA (1996) Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.Anticancer Res 16(5 A):2581–2587

    PubMed  CAS  Google Scholar 

  • Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, Linzer DG, Machac J (1997) The role of

    Google Scholar 

  • thallium-201 uptake and retention in intracranial tumors after radiotherapy, J Nucl Med 38(2):223–226

    Google Scholar 

  • Miyamoto C, Brady LW, Rackover M, Emrich J, Class, R, Bender H, Dadparvar S, Woo D, Young T, Eshleman J, Dilling T, Micaily B, Steplewski Z, Koprowski H, Black P, Nair S, McCormack T (1995) Utilization of 125 I Monoclonal Antibody in the Management of Primary Glioblastoma Multiforme. Radiation Oncology Investigations 3:126–132

    Article  Google Scholar 

  • Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, Curran WJ Jr (1995) Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83–02. Int J Radiat Oncol Biol Phys 31(3):83–02

    Article  PubMed  CAS  Google Scholar 

  • Nakagawa H, Fujita T, Kubo S, Tsuruzono K, Yamada M, Tokiyoshi K, Miyawaki Y, Kanayama T, Kadota T, Hayakawa T (1994) Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Surg Neurol 41(1):19–27

    Article  PubMed  CAS  Google Scholar 

  • Natali PG, Nicotra MR, Bigotti A, Botti C, Castellani P, Risso AM, Zardi L (1991) Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer 47(6):811–816

    Article  PubMed  CAS  Google Scholar 

  • Nelson DF, Yuh WT, Wen BC, Ryals TJ, Cornell SH (1990) Cerebral necrosis simulating an intraparenchymal tumor. AJNR Am J Neuroradiol 11(1):211–212

    PubMed  CAS  Google Scholar 

  • Nijjar TS, Simpson WJ, Gadalla T, et al. (1993) Oligodendroglioma: the Princess Margaret Hospital experience (1958–1984). Cancer 71:1958–1984

    Article  PubMed  CAS  Google Scholar 

  • Ortiz de Urbina D, Santos M, Garcia-Berrocal I, Bustos JC, Samblas J, Gutierrez-Diaz JA, Delgado JM, Donckaster G, Calvo FA (1995) Intraoperative radiation therapy in malignant glioma: early clinical results. Neurol Res 17(4):289–294

    PubMed  CAS  Google Scholar 

  • Ostertag CB, Kreth FW (1992) Iodine-125 interstitial irradiation for cerebral gliomas. Acta Neurochir (Wien) 119(1–4):1–4

    Article  CAS  Google Scholar 

  • Packer RJ, Siegel KR, Schut L, Gruce DA, Sutton LN and Litmann P (1985) Central nervous system spread of childhood brain tumors at diagnosis or at initial disease recurrence, Concepts Pediatr. Neurosurg 6:16–24

    Google Scholar 

  • Patchell RA, Yaes RJ, Beach L, Kryscio RJ, Davis DG, Tibbs PA, Young B (1997) A phase I trial of neutron brachytherapy for the treatment of malignant gliomas. Br J Radiol 70(839):1162–1168

    PubMed  CAS  Google Scholar 

  • Patel K, Rossell RJ, Pemberton LF, Cheung NK, Walsh FS, Moore SE, Sugimoto T, Kemshead JT (1989) Monoclonal antibody 3F8 recognizes the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2. Br J Cancer 60(6):861–866

    Article  PubMed  CAS  Google Scholar 

  • Peters LJ, Withers HR, Thames HD Jr, Fletcher GH (1982) Tumor radioresistance in clinical radiotherapy. Int J Radiat Oncol Biol Phys 8(1):101–108

    Article  PubMed  CAS  Google Scholar 

  • Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler

    Google Scholar 

  • KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB (1998) Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys 40(1):57–63

    Article  Google Scholar 

  • Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Uratsun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ (1999) A phase 3 randomized study of radiotherapy plus Procarbazine, CCNU, and Vincristine (PVC)with or without BudR for the treatment of anaplasticastocytoma: a preliminary report of RTOG 9404. Int. J. Radiation Oncology Biol Phys 45(5):1109–1115

    Article  CAS  Google Scholar 

  • Press OW, Vitetta ES, Farr AG, Hansen JA, Martin PJ (1986) Evaluation of ricin A-chain immunotoxins directed

    Google Scholar 

  • against human T cells. Cell Immunol 102(1):10–20

    Google Scholar 

  • Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC 4th, Ingle JN, Cascino TL (1999) Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.Neurosurgery 44(1):67–73

    Google Scholar 

  • Reifenberger G, Prior R, Deckert M, Wechsler W (1989) Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch A Pathol Anat Histopathol 414(2):147–155

    Article  PubMed  CAS  Google Scholar 

  • Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19(3):407–413

    PubMed  CAS  Google Scholar 

  • Salazar OM and Rubin P (1976) The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys1:627–637

    Google Scholar 

  • Sarkaria JN, Mehta MP, Loeffler JS, Buatti JM, Chappell RJ, Levin AB, Alexander E rd, Friedman WA, Kinsella TJ (1995) Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32(4):931–941

    Article  PubMed  CAS  Google Scholar 

  • Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, etal. (1992) High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24(4):583–591

    Article  PubMed  CAS  Google Scholar 

  • Schupak K, Malkin M, Anderson L, Arbit E, Lindsley K, Leibel S (1995) The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence. Int J Radiat Oncol Biol Phys 32(4):1167–1176

    Article  PubMed  CAS  Google Scholar 

  • Schwartz JL, Rotmensch J, Giovanazzi S, Cohen MB, Weichselbaum RR (1988) Faster repair of DNA doublestrand breaks in radioresistant human tumor cells. Int J Radiat Oncol Biol Phys 15(4):907–912

    Article  PubMed  CAS  Google Scholar 

  • Scheibel RS, Meyers CA, Levin VA (1996) Cognitive dysfunction following surgery for intracerebral glioma: influenceof histopathology, lesion location, and treatment. J Neurooncol 30(1):61–69

    Article  PubMed  CAS  Google Scholar 

  • Shibamoto Y, Nishimura Y, Tsutsui K, Sasai K, Takahashi M, Abe M (1997) Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma. Jpn J Clin Oncol 27(1):31–36

    Article  PubMed  CAS  Google Scholar 

  • Shibamoto Y, Yamashita J, Takahashi M, Abe M (1994) Intraoperative radiation therapy for braintumors with emphasis on retreatment for recurrence following full-dose external beam irradiation. Am J Clin Oncol 17(5):396–399

    Article  PubMed  CAS  Google Scholar 

  • Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6(9):1215–1228

    Google Scholar 

  • Shrieve DC, Alexander E 3rd, Black PM, Wen PY, Fine HA, Kooy HM, Loeffler JS (1999) Treatment of patients with primary glioblastoma multiforme with standard post-operative radiotherapy and radiosurgical boost: prognostic cf actors and long-term outcome. J Neurosurg 90(1):72–77

    Article  PubMed  CAS  Google Scholar 

  • Silverstein MD, Cascino TL, Harmsen WS (1996) High-grade astrocytomas: resource use, clinical outcomes, and cost of care. Mayo Clin Proc 71(10):936–944

    PubMed  CAS  Google Scholar 

  • Sipos EP, Tyler B, Piantoadosi S, Burger PC, Brem H (1997) Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemothera Pharmacol 39(5):383–389

    Article  CAS  Google Scholar 

  • Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, Scharfen CO, Weaver KA, Wara WM (1994) Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29(4):719–727

    Article  PubMed  CAS  Google Scholar 

  • Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Dubray BM, Brock WA (1992) Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 22(2):241–246

    Article  PubMed  CAS  Google Scholar 

  • Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery41(1):44–48; discussion 44–48

    Google Scholar 

  • Van Tassel P, Bruner JM, Maor MH, Leeds NE, Gleason MJ, Yung WK, Levin VA (1995) MR of toxic effects of accelerated fractionation radiation therapy and carboplatin chemotherapy for malignant gliomas. AJNR Am J Neuroradiol 16(4):715–726

    PubMed  CAS  Google Scholar 

  • Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B, Williams J (1997) Cell-cycle arrest versus cell death in cancer therapy. Nat Med 3(9):1034–1036

    Article  PubMed  CAS  Google Scholar 

  • Walker MD, Alexander E Jr, Hunt WE, MacCarty CSW, Mahaley MS, Mealey J, Norrel HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike A (1978): Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trail. J Neurosurg 49: 333–343

    Article  PubMed  CAS  Google Scholar 

  • Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Healey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323–1329

    Article  PubMed  CAS  Google Scholar 

  • Wang CC (1988) Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys14(6):1143–1146

    Article  PubMed  CAS  Google Scholar 

  • Wlodek D, Hittelman WN (1987) The repair of double-strand DNA breaks correlates with radiosensitivity of L5178Y-S and L5178Y-R cells. Radiat Res 112(1):146–155

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Miyamoto, C. (2003). Radiation Therapy Principles for High-Grade Gliomas. In: Petrovich, Z., Brady, L.W., Apuzzo, M.L.J., Bamberg, M. (eds) Combined Modality Therapy of Central Nervous System Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56411-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56411-6_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00627-5

  • Online ISBN: 978-3-642-56411-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics